These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12857926)

  • 21. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
    Bartz SR; Vodicka MA
    Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A sorting signal for the basolateral delivery of the vesicular stomatitis virus (VSV) G protein lies in its luminal domain: analysis of the targeting of VSV G-influenza hemagglutinin chimeras.
    Compton T; Ivanov IE; Gottlieb T; Rindler M; Adesnik M; Sabatini DD
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4112-6. PubMed ID: 2542964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein.
    Barsoum J; Brown R; McKee M; Boyce FM
    Hum Gene Ther; 1997 Nov; 8(17):2011-8. PubMed ID: 9414250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.
    de Parseval A; Elder JH
    J Virol; 2001 May; 75(10):4528-39. PubMed ID: 11312323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions.
    Johnson JE; Rodgers W; Rose JK
    Virology; 1998 Nov; 251(2):244-52. PubMed ID: 9837788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.
    Burns JC; Friedmann T; Driever W; Burrascano M; Yee JK
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8033-7. PubMed ID: 8396259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations.
    Clarke DK; Nasar F; Lee M; Johnson JE; Wright K; Calderon P; Guo M; Natuk R; Cooper D; Hendry RM; Udem SA
    J Virol; 2007 Feb; 81(4):2056-64. PubMed ID: 17151112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity.
    Delamarre L; Rosenberg AR; Pique C; Pham D; Dokhélar MC
    J Virol; 1997 Jan; 71(1):259-66. PubMed ID: 8985345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins.
    Okuma K; Matsuura Y; Tatsuo H; Inagaki Y; Nakamura M; Yamamoto N; Yanagi Y
    J Gen Virol; 2001 Apr; 82(Pt 4):821-830. PubMed ID: 11257187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein.
    Nikolic J; Belot L; Raux H; Legrand P; Gaudin Y; A Albertini A
    Nat Commun; 2018 Mar; 9(1):1029. PubMed ID: 29531262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
    Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D
    Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector.
    Ezelle HJ; Markovic D; Barber GN
    J Virol; 2002 Dec; 76(23):12325-34. PubMed ID: 12414973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Ralpha2 receptor of malignant glioma cells.
    Zhou G; Roizman B
    J Virol; 2005 May; 79(9):5272-7. PubMed ID: 15827141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant vesicular stomatitis viruses encoding simian immunodeficiency virus receptors target infected cells and control infection.
    Okuma K; Boritz E; Walker J; Sarkar A; Alexander L; Rose JK
    Virology; 2006 Mar; 346(1):86-97. PubMed ID: 16325218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts.
    Arai T; Takada M; Ui M; Iba H
    Virology; 1999 Jul; 260(1):109-15. PubMed ID: 10405362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein.
    Yang Y; Vanin EF; Whitt MA; Fornerod M; Zwart R; Schneiderman RD; Grosveld G; Nienhuis AW
    Hum Gene Ther; 1995 Sep; 6(9):1203-13. PubMed ID: 8527479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using G-deleted vesicular stomatitis virus to probe the innate anti-viral response.
    Lai F; Kazdhan N; Lichty BD
    J Virol Methods; 2008 Nov; 153(2):276-9. PubMed ID: 18692525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.